Drug intelligence / Profile preview

shenqiyichang granule

Development stage: Unknown
Administration: Oral

Overview

Shenqiyichang Granule (also known as Shenqi Yichang granules or SQYCG) is a traditional Chinese medicine formulation used primarily as an adjuvant therapy in the treatment of colorectal cancer. It is composed of multiple herbal ingredients and has demonstrated efficacy in supporting conventional cancer treatments by improving patient outcomes. The precise mechanism of action remains unclear; however, it is believed to exert immunomodulatory and anti-tumor effects through the synergistic actions of its herbal components. The product is developed and manufactured by companies specializing in traditional Chinese medicines[1].

Brand names: Shenqiyichang GranuleShenqi Yichang granulesSQYCG
Other names: Shenqiyichang GranuleShenqi Yichang granulesSQYCG

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on shenqiyichang granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on shenqiyichang granule.

Explore the full profile